Liquidia (LQDA) Accounts Payables (2019 - 2026)
Liquidia (LQDA) posted quarterly Accounts Payables of $11.0 million for Q1 2026, up 26.58% year-over-year from $8.7 million in Q1 2025, and up 198.56% quarter-over-quarter from $3.7 million in Q4 2025.
Liquidia (LQDA) Accounts Payables (2019 - 2026) Analysis & Trends
Liquidia's Accounts Payables history runs 8 years deep, the most recent figure standing at $11.0 million for Q1 2026.
- In Q1 2026, Accounts Payables rose 26.58% year-over-year to $11.0 million; the TTM figure through Mar 2026 stood at $11.0 million (up 26.58% YoY), while the FY2025 annual figure was $3.7 million, down 21.56% from the prior year.
- Accounts Payables for Q1 2026 stood at $11.0 million, up from $3.7 million in the prior quarter.
- The five-year high for Accounts Payables was $11.3 million in Q2 2025, with the low at $841000.0 in Q1 2023.
- The 5-year median for Accounts Payables is $2.3 million (2024), against an average of $4.0 million.
- The sharpest annual moves came in 2023 and 2025: Accounts Payables plunged 49.52% in 2023, then jumped 248.39% in 2025.
- Liquidia's Accounts Payables stood at $2.2 million in 2022, then plunged by 36.46% to $1.4 million in 2023, then jumped by 235.89% to $4.7 million in 2024, then fell by 21.56% to $3.7 million in 2025, then soared by 198.56% to $11.0 million in 2026.
- Business Quant data shows LQDA's Accounts Payables at $11.0 million in Q1 2026, $3.7 million in Q4 2025, and $6.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 356.00 Mn |
| 10 | Liquidia | 6.34 Bn | 6.05 Bn | 160.92 Mn | 12.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.75 Mn |
| Mar 31, 2026 | 10.98 Mn |
| Dec 31, 2025 | 3.68 Mn |
| Sep 30, 2025 | 6.02 Mn |
| Jun 30, 2025 | 11.35 Mn |
| Mar 31, 2025 | 8.68 Mn |
| Dec 31, 2024 | 4.69 Mn |
| Sep 30, 2024 | 2.30 Mn |
| Jun 30, 2024 | 5.74 Mn |
| Mar 31, 2024 | 2.49 Mn |
| Dec 31, 2023 | 1.40 Mn |
| Sep 30, 2023 | 1.81 Mn |
| Jun 30, 2023 | 1.92 Mn |
| Mar 31, 2023 | 841,000.00 |
| Dec 31, 2022 | 2.20 Mn |
| Sep 30, 2022 | 1.14 Mn |
| Jun 30, 2022 | 1.41 Mn |
| Mar 31, 2022 | 1.67 Mn |
| Dec 31, 2021 | 1.07 Mn |
| Sep 30, 2021 | 1.61 Mn |